Boston Scientific Corporation (BSX)

NYSE: BSX · IEX Real-Time Price · USD

76.55

+0.14 (0.18%)

At close: Jul 2, 2024, 4:00 PM

76.03

-0.52 (-0.68%)

After-hours: Jul 2, 2024, 7:50 PM EDT

Boston Scientific Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 1994
Net Income	1,570	642	985	-115	4,700	Upgrade
Depreciation & Amortization	1,196	1,136	1,093	1,123	1,011	Upgrade
Share-Based Compensation	233	220	194	170	157	Upgrade
Other Operating Activities	-519	-528	-458	297	-4,032	Upgrade
Operating Cash Flow	2,503	1,526	1,870	1,508	1,836	Upgrade
Operating Cash Flow Growth	64.02%	-18.40%	24.01%	-17.86%	492.26%	Upgrade
Capital Expenditures	-677	-506	-458	-277	-402	Upgrade
Acquisitions	-1,900	-1,561	-1,153	-134	-4,441	Upgrade
Change in Investments	2	56	15	0	-199	Upgrade
Other Investing Activities	1	-	-1	-	1	Upgrade
Investing Cash Flow	-2,574	-2,011	-1,597	-411	-5,041	Upgrade
Share Issuance / Repurchase	126	83	60	492	58	Upgrade
Debt Issued / Paid	-4	-165	0	-999	2,794	Upgrade
Other Financing Activities	-117	-466	-155	800	121	Upgrade
Financing Cash Flow	5	-548	-95	293	2,973	Upgrade
Net Cash Flow	-70	-1,042	173	1,388	-222	Upgrade
Free Cash Flow	1,826	1,020	1,412	1,231	1,434	Upgrade
Free Cash Flow Growth	79.02%	-27.76%	14.70%	-14.16%	17825.00%	Upgrade
Free Cash Flow Margin	12.82%	8.04%	11.88%	12.42%	13.36%	Upgrade
Free Cash Flow Per Share	1.26	0.71	0.99	0.87	1.03	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).